Date Filed | Type | Description |
10/04/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
08/15/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
06/29/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/29/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/12/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
04/24/2023 |
8-K
| Quarterly results |
04/18/2023 |
8-K
| Quarterly results |
04/13/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
04/05/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
03/13/2023 |
4
| Engelson Erik T. (President and Chief Executive) has filed a Form 4 on Lucira Health, Inc.
Txns:
| Sold 574,666 shares
@ $1.03, valued at
$591.9k
Sold 60,000 shares
@ $1.09, valued at
$65.4k
Exercised 574,666 options to buy
@ $0.82, valued at
$471.2k
|
|
03/13/2023 |
4
| Narido Richard Clavano (CFO) has filed a Form 4 on Lucira Health, Inc.
Txns:
| Sold 10,674 shares
@ $1.14, valued at
$12.2k
Sold 9,675 shares
@ $1.07, valued at
$10.4k
Sold 4,742 shares
@ $1, valued at
$4.7k
Sold 1,910 shares
@ $0.57, valued at
$1.1k
Sold 2,382 shares
@ $0.45, valued at
$1.1k
|
|
03/13/2023 |
4
| Collins Kevin Walter (Chief Revenue Officer) has filed a Form 4 on Lucira Health, Inc.
Txns:
| Sold 30,102 shares
@ $1.15, valued at
$34.6k
Sold 81,717 shares
@ $0.48, valued at
$39.2k
|
|
03/13/2023 |
4
| Allen Anthony Joseph (Chief Operations Officer) has filed a Form 4 on Lucira Health, Inc.
Txns:
| Sold 8,405 shares
@ $1, valued at
$8.4k
|
|
02/27/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure... |
02/22/2023 |
8-K
| Bankruptcy or Receivership, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer... |
01/13/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
12/28/2022 |
8-K
| Quarterly results |
12/22/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
8-K
| Quarterly results |
12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/15/2022 |
8-K
| Quarterly results |
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/25/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
11/14/2022 |
8-K
| Quarterly results |
11/01/2022 |
8-K
| Quarterly results |
10/26/2022 |
8-K
| Quarterly results |
09/22/2022 |
4
| Allen Anthony Joseph (Chief Operations Officer) has filed a Form 4 on Lucira Health, Inc.
Txns:
| Sold 17,052 shares
@ $1.39, valued at
$23.7k
|
|
|